Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tibet Rhodiola Pharmaceutical Holding Co stock Dividend Yield % is close to 1-year high.
During the past 12 months, Tibet Rhodiola Pharmaceutical Holding Co's average Dividends Per Share Growth Rate was -10.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 93.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 39.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 43.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Tibet Rhodiola Pharmaceutical Holding Co was 98.80% per year. The lowest was 8.60% per year. And the median was 43.60% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Tibet Rhodiola Pharmaceutical Holding Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Tibet Rhodiola Pharmaceutical Holding Co was 1.89. The lowest was 0.17. And the median was 0.48.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Tibet Rhodiola Pharmaceutical Holding Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.876000
2026-05-22
2026-05-21
2026-05-22
Cash Dividend
quarterly
CNY:CNY 1.000000
CNY 0.881000
2025-09-01
2025-08-29
2025-09-01
Cash Dividend
quarterly
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Tibet Rhodiola Pharmaceutical Holding Co's Dividend Yield (%) for Today is calculated as
Current Share Price is ¥38.17.
Tibet Rhodiola Pharmaceutical Holding Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥1.757.
During the past 13 years, the highest Dividend Yield of Tibet Rhodiola Pharmaceutical Holding Co was 5.32%. The lowest was 0.33%. And the median was 1.18%.
Good Sign:
Tibet Rhodiola Pharmaceutical Holding Co stock Dividend Yield % is close to 1-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tibet Rhodiola Pharmaceutical Holding Co Dividends per Share Related Terms
Tibet Rhodiola Pharmaceutical Holding Co Dividends per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tibet Rhodiola Pharmaceutical Holding Co Dividends per Share Chart
Tibet Rhodiola Pharmaceutical Holding Co Annual Data
SHSE:600211 vs ZTS: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Rhodiola Pharmaceutical Holding Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tibet Rhodiola Pharmaceutical Holding Co Dividend Yield % vs Drug Manufacturers Industry
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) has a Dividends per Share of ¥1.61 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Tibet Rhodiola Pharmaceutical Holding Co and its competitors.
Is Tibet Rhodiola Pharmaceutical Holding Co's Dividends per Share too high?
Tibet Rhodiola Pharmaceutical Holding Co's current Dividends per Share is ¥1.61. Overall, Tibet Rhodiola Pharmaceutical Holding Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tibet Rhodiola Pharmaceutical Holding Co's Dividends per Share compare to ZTS?
Tibet Rhodiola Pharmaceutical Holding Co's Dividends per Share of ¥1.61 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Tibet Rhodiola Pharmaceutical Holding Co and its competitors. Tibet Rhodiola Pharmaceutical Holding Co's current Dividends per Share is ¥1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tibet Rhodiola Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) is currently considered Fairly Valued. The stock's GF Value™ is ¥40.76, compared to a current price of ¥38.17 — trading 6.4% below its estimated fair value. The current Dividends per Share is ¥1.61. Tibet Rhodiola Pharmaceutical Holding Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211), the current Dividends per Share is ¥1.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Overvalued in 2026?
Based on GuruFocus' analysis, Tibet Rhodiola Pharmaceutical Holding Co stock appears to be undervalued.
The current stock price of ¥38.17 is trading 6.4% below its estimated GF Value™ of ¥40.76.
GuruFocus considers Tibet Rhodiola Pharmaceutical Holding Co to be Fairly Valued.
Key valuation signals for SHSE:600211:
Dividends per Share: ¥1.61
GF Value™: ¥40.76 vs. price of ¥38.17 (6.4% below fair value)
No single metric tells the full story. See the SHSE:600211 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tibet Rhodiola Pharmaceutical Holding Co Business Description
Tibet Rhodiola Pharmaceutical Holding Co is a pharmaceutical company engaged in the production and sales of capsules, biological agents, granules, and coatings. The company's products cover biopharmaceuticals, Tibetan medicine, traditional Chinese medicine, and chemical drugs, involving fields such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines.
95GF Score
Get the complete analysis for SHSE:600211
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600211 has been successfully added to your 
